A secondary analysis of the phase 3 KEYNOTE-716 trial finds that adjuvant Keytruda improves recurrence-free survival without increasing the risk of new primary melanoma and may reduce non-melanoma ...

There was once a rumour he’d undergone a facelift, which he has shut down. Gordon clarified that a bandage on his face in 2025 was due to the removal of a basal cell carcinoma, a type of skin cancer, ...

Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

Researchers examined trends in the utilization of various surgical procedures for skin cancer stratified by patient skin color.

Delayed full-thickness skin grafting after skin cancer resection was associated with a higher rate of graft success than immediate skin grafting.

February 2026 proved to be a pivotal month for the oncology landscape, as the FDA green-lit several therapies targeting some ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI ® (encorafenib) in combination with cetuximab ...

PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported topline results from a Phase 2 clinical trial evaluating a ...

Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with dermatomyositis usually require prompt treatment with intense ...

Dr. Carolyn Mukai, ND, Dr. Lynn Klassen, ND, Dr. Ece Toprak, ND Expanding recognition of infection-triggered ...

Spots, bumps or patches that suddenly appear on your skin can be alarming, especially if they grow quickly, become red or irritated, or do not seem to heal. It can be difficult to tell whether it is ...

Hair regrowth treatment may soon take a major leap forward, as researchers in a recent study have successfully grown complete ...